{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:32:31Z","timestamp":1790904751583,"version":"4.1.0"},"reference-count":95,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T00:00:00Z","timestamp":1771891200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2025ZD0543900"],"award-info":[{"award-number":["2025ZD0543900"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82573485"],"award-info":[{"award-number":["82573485"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Breast cancer is a heterogeneous malignancy that often changes during diagnosis and treatment, so timely monitoring of tumors, patients and treatment responses is crucial to improve the prognosis of patients. With the development of precision oncology, early patient stratification and the formulation of tailored therapeutic approaches have become essential strategies to maximize treatment efficacy. Several techniques, such as molecular pathology and genomics analysis have been thoroughly studied in the diagnosis and treatment of breast cancer, but they only evaluate and analyze from the perspective of patients or tumors in isolation. Metabolomics uses high-throughput analytical techniques to provide a functional readout of the biological phenotype, reflecting the sum of alterations occurring at the DNA, RNA, and protein levels. Therefore, through the detection of tumor tissues and peripheral blood of patients, metabolomics could describe the bidirectional interaction between the tumor and its microenvironment, as well as the systemic metabolic changes in patients to evaluate cancer progression from both tumor and patient aspects in a more comprehensive way. In this review, we summarize the currently available techniques for metabolomics and how metabolomics can be used to improve the clinical management of breast cancer patients, including diagnosis, treatment, and prognosis. We also discuss current challenges and future directions in metabolomics research.<\/jats:p>","DOI":"10.3390\/ijms27052114","type":"journal-article","created":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:58:18Z","timestamp":1771952298000},"page":"2114","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Applications of Metabolomics to the Clinical Management of Breast Cancer: New Perspectives for Diagnosis, Treatment and Prognosis"],"prefix":"10.3390","volume":"27","author":[{"given":"Yuqiu","family":"Li","sequence":"first","affiliation":[{"name":"Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2887-7985","authenticated-orcid":false,"given":"Hongnan","family":"Mo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, No. 17 Panjiayuan Nanli, Chaoyang District, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,2,24]]},"reference":[{"key":"ref_1","first-page":"209","article-title":"Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.molonc.2014.03.022","article-title":"Comparison of frequencies and prognostic effect of molecular subtypes between young and elderly breast cancer patients","volume":"8","author":"Bastiaannet","year":"2014","journal-title":"Mol. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"e1481","DOI":"10.1634\/theoncologist.2019-0982","article-title":"Molecular Subtyping of Triple-Negative Breast Cancers by Immunohistochemistry: Molecular Basis and Clinical Relevance","volume":"25","author":"Zhao","year":"2020","journal-title":"Oncologist"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1200\/JCO.2013.54.1870","article-title":"Luminal B breast cancer: Molecular characterization, clinical management, and future perspectives","volume":"32","author":"Ades","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/jcmm.17124","article-title":"Recent advances of transcriptomics and proteomics in triple-negative breast cancer prognosis assessment","volume":"26","author":"Li","year":"2022","journal-title":"J. Cell. Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.annonc.2023.11.016","article-title":"Early breast cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"35","author":"Loibl","year":"2024","journal-title":"Ann. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"5678","DOI":"10.1158\/1078-0432.CCR-04-2421","article-title":"Breast cancer molecular subtypes respond differently to preoperative chemotherapy","volume":"11","author":"Rouzier","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"10393","DOI":"10.1073\/pnas.1732912100","article-title":"Breast cancer classification and prognosis based on gene expression profiles from a population-based study","volume":"100","author":"Sotiriou","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/415530a","article-title":"Gene expression profiling predicts clinical outcome of breast cancer","volume":"415","author":"Dai","year":"2002","journal-title":"Nature"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1158\/1078-0432.CCR-06-1109","article-title":"The triple negative paradox: Primary tumor chemosensitivity of breast cancer subtypes","volume":"13","author":"Carey","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Phung, M.T., Tin, S.T., and Elwood, J.M. (2019). Prognostic models for breast cancer: A systematic review. BMC Cancer, 19.","DOI":"10.1186\/s12885-019-5442-6"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chiru, E., Kuhar, C.G., Oseledchyk, A., Sch\u00f6tzau, A., Javier-Gonz\u00e1lez, M., Kurzeder, C., and Vetter, M. (2023). Clinical application of the 21-gene oncotype recurrence score in an older cohort: A single center experience. Transl. Oncol., 36.","DOI":"10.1016\/j.tranon.2023.101724"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1056\/NEJMoa1602253","article-title":"70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer","volume":"375","author":"Cardoso","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S1470-2045(17)30891-4","article-title":"Germline BRCA mutation and outcome in young-onset breast cancer (POSH): A prospective cohort study","volume":"19","author":"Copson","year":"2018","journal-title":"Lancet Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"D801","DOI":"10.1093\/nar\/gks1065","article-title":"HMDB 3.0\u2014The Human Metabolome Database in 2013","volume":"41","author":"Wishart","year":"2013","journal-title":"Nucleic Acids Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrc1390","article-title":"Metabolic profiles of cancer cells","volume":"4","author":"Griffin","year":"2004","journal-title":"Nat. Rev. Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1152\/physrev.00035.2018","article-title":"Metabolomics for Investigating Physiological and Pathophysiological Processes","volume":"99","author":"Wishart","year":"2019","journal-title":"Physiol. Rev."},{"key":"ref_18","first-page":"333","article-title":"Metabolomics in cancer research and emerging applications in clinical oncology","volume":"71","author":"Schmidt","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.cbpa.2017.01.012","article-title":"Epimetabolites: Discovering metabolism beyond building and burning","volume":"36","author":"Showalter","year":"2017","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_20","first-page":"e1795","article-title":"Metabolomics in oncology","volume":"6","author":"Suri","year":"2023","journal-title":"Cancer Rep."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Fukano, M., Park, M., and Deblois, G. (2021). Metabolic Flexibility Is a Determinant of Breast Cancer Heterogeneity and Progression. Cancers, 13.","DOI":"10.3390\/cancers13184699"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Lei, P., Wang, W., Sheldon, M., Sun, Y., Yao, F., and Ma, L. (2023). Role of Glucose Metabolic Reprogramming in Breast Cancer Progression and Drug Resistance. Cancers, 15.","DOI":"10.3390\/cancers15133390"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.20892\/j.issn.2095-3941.2019.0210","article-title":"Metabolic reprogramming in triple-negative breast cancer","volume":"17","author":"Wang","year":"2020","journal-title":"Cancer Biol. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1002\/jmri.23945","article-title":"MR spectroscopic imaging: Principles and recent advances","volume":"37","author":"Posse","year":"2013","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1200\/JCO.22.02754","article-title":"Application of Metabolomics to Epidemiologic Studies of Breast Cancer: New Perspectives for Etiology and Prevention","volume":"42","author":"His","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11306-016-1157-8","article-title":"A relative quantitative positive\/negative ion switching method for untargeted lipidomics via high resolution LC-MS\/MS from any biological source","volume":"13","author":"Breitkopf","year":"2017","journal-title":"Metabolomics"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Emwas, A.-H., Roy, R., McKay, R.T., Tenori, L., Saccenti, E., Gowda, G.A.N., Raftery, D., Alahmari, F., Jaremko, L., and Jaremko, M. (2019). NMR Spectroscopy for Metabolomics Research. Metabolites, 9.","DOI":"10.3390\/metabo9070123"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/mas.21562","article-title":"Challenges and emergent solutions for LC-MS\/MS based untargeted metabolomics in diseases","volume":"37","author":"Cui","year":"2018","journal-title":"Mass Spectrom. Rev."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Couacault, P., Avella, D., Londo\u00f1o-Osorio, S., Lorenzo, A.S., Gradillas, A., K\u00e4rkk\u00e4inen, O., Want, E., and Witting, M. (2024). Targeted and untargeted metabolomics and lipidomics in dried blood microsampling: Recent applications and perspectives. Anal. Sci. Adv., 5.","DOI":"10.1002\/ansa.202400002"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1007\/s13361-016-1469-y","article-title":"Untargeted Metabolomics Strategies\u2014Challenges and Emerging Directions","volume":"27","author":"Codreanu","year":"2016","journal-title":"J. Am. Soc. Mass. Spectrom."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1021\/acs.analchem.5b04491","article-title":"Toward Merging Untargeted and Targeted Methods in Mass Spectrometry-Based Metabolomics and Lipidomics","volume":"88","author":"Cajka","year":"2016","journal-title":"Anal. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"4876","DOI":"10.1021\/pr2004874","article-title":"Characterization of the human tear metabolome by LC-MS\/MS","volume":"10","author":"Chen","year":"2011","journal-title":"J. Proteome Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.3892\/mmr.2017.6758","article-title":"Metabolomic analysis based on 1H-nuclear magnetic resonance spectroscopy metabolic profiles in tuberculous, malignant and transudative pleural effusion","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.talanta.2017.09.028","article-title":"Metabolomics analysis of human sweat collected after moderate exercise","volume":"177","year":"2018","journal-title":"Talanta"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Gardner, A., Carpenter, G., and So, P.-W. (2020). Salivary Metabolomics: From Diagnostic Biomarker Discovery to Investigating Biological Function. Metabolites, 10.","DOI":"10.3390\/metabo10020047"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/pros.20727","article-title":"The metabolites citrate, myo-inositol, and spermine are potential age-independent markers of prostate cancer in human expressed prostatic secretions","volume":"68","author":"Serkova","year":"2008","journal-title":"Prostate"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1089\/omi.2012.0090","article-title":"Cell metabolomics","volume":"17","author":"Zhang","year":"2013","journal-title":"Omics"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jbiotec.2009.07.010","article-title":"Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells","volume":"144","author":"Metallo","year":"2009","journal-title":"J. Biotechnol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1158\/1055-9965.EPI-21-1023","article-title":"Plasma Metabolomics and Breast Cancer Risk over 20 Years of Follow-up among Postmenopausal Women in the Nurses\u2019 Health Study","volume":"31","author":"Brantley","year":"2022","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1038\/s41416-021-01304-1","article-title":"Investigation of circulating metabolites associated with breast cancer risk by untargeted metabolomics: A case\u2013control study nested within the French E3N cohort","volume":"124","author":"Jobard","year":"2021","journal-title":"Br. J. Cancer"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s13058-024-01896-5","article-title":"Plasma metabolomics profiles and breast cancer risk","volume":"26","author":"Wu","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa052911","article-title":"Diagnostic Performance of Digital versus Film Mammography for Breast-Cancer Screening","volume":"353","author":"Pisano","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Anh, N.K., Lee, A., Phat, N.K., Yen, N.T.H., Thu, N.Q., Tien, N.T.N., Kim, H.-S., Kim, T.H., Kim, D.H., and Kim, H.-Y. (2024). Combining metabolomics and machine learning to discover biomarkers for early-stage breast cancer diagnosis. PLoS ONE, 19.","DOI":"10.1371\/journal.pone.0311810"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"3124","DOI":"10.1021\/acs.jproteome.1c00019","article-title":"Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics","volume":"20","author":"Wei","year":"2021","journal-title":"J. Proteome Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ymeth.2024.01.003","article-title":"LC-MS\/MS platform-based serum untargeted screening reveals the diagnostic biomarker panel and molecular mechanism of breast cancer","volume":"222","author":"Gong","year":"2024","journal-title":"Methods"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1186\/s12967-024-05843-y","article-title":"Comprehensive analysis of the metabolomics and transcriptomics uncovers the dysregulated network and potential biomarkers of Triple Negative Breast Cancer","volume":"22","author":"Gong","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e1550","DOI":"10.1002\/ctm2.1550","article-title":"Image-guided metabolomics and transcriptomics reveal tumour heterogeneity in luminal A and B human breast cancer beyond glucose tracer uptake","volume":"14","author":"Yang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"The Cancer Genome Atlas Network (2012). Comprehensive molecular portraits of human breast tumours. Nature, 490, 61\u201370.","DOI":"10.1038\/nature11412"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"906","DOI":"10.7326\/0003-4819-105-6-906","article-title":"Standard and computed tomography in the evaluation of neoplasms of the chest. A comparative efficacy assessment","volume":"105","author":"Inouye","year":"1986","journal-title":"Ann. Intern. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s00432-002-0342-5","article-title":"Comparing whole body (18)F-2-deoxyglucose positron emission tomography and technetium-99m methylene diphosphonate bone scan to detect bone metastases in patients with breast cancer","volume":"128","author":"Yang","year":"2002","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Huang, W., Ye, J., Qiu, Y., Peng, W., Lan, N., Huang, T., Ou, Y., Deng, X., and Li, Y. (2021). Ultrasound-Guided Percutaneous Core Needle Biopsy of Peripheral Pulmonary Nodules \u22642 cm: Diagnostic Performance, Safety and Influence Factors. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.671884"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s12282-024-01579-1","article-title":"Global untargeted and individual targeted plasma metabolomics of breast cancer recurrence modified by hormone receptors","volume":"31","author":"Yang","year":"2024","journal-title":"Breast Cancer"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Zhang, H., Yang, F., Xu, Y., Zhao, S., Jiang, Y.-Z., Shao, Z.-M., and Xiao, Y. (2025). Multimodal integration using a machine learning approach facilitates risk stratification in HR+\/HER2\u2212 breast cancer. Cell Rep. Med., 6.","DOI":"10.1016\/j.xcrm.2024.101924"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Ye, H., Shen, X., Li, Y., Zou, W., Hassan, S.S.U., Feng, Y., Wang, X., Tian, J., Shao, X., and Tao, Y. (2024). Proteomic and metabolomic characterization of bone, liver, and lung metastases in plasma of breast cancer patients. Proteom. Clin. Appl., 18.","DOI":"10.1002\/prca.202300136"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Vicente-Munoz, S., Hunt, B.G., Lange, T.E., Wells, S.I., and Waltz, S.E. (2022). NMR-based metabolomic analysis identifies RON-DEK-\u03b2-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0274128"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/s41598-023-50866-y","article-title":"1H-NMR metabolomics analysis identifies hypoxanthine as a novel metastasis-associated metabolite in breast cancer","volume":"14","author":"Shakartalla","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.ccell.2019.02.001","article-title":"Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment Strategies","volume":"35","author":"Jiang","year":"2019","journal-title":"Cancer Cell"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.ctrv.2018.06.005","article-title":"Androgen receptor in triple negative breast cancer: A potential target for the targetless subtype","volume":"68","author":"Gerratana","year":"2018","journal-title":"Cancer Treat. Rev."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1093\/annonc\/mdw067","article-title":"A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1)","volume":"27","author":"Bonnefoi","year":"2016","journal-title":"Ann. Oncol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1200\/JCO.2016.71.3495","article-title":"Enzalutamide for the Treatment of Androgen Receptor-Expressing Triple-Negative Breast Cancer","volume":"36","author":"Traina","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4048\/jbc.2015.18.2.134","article-title":"Influence of Androgen Receptor Expression on the Survival Outcomes in Breast Cancer: A Meta-Analysis","volume":"18","author":"Kim","year":"2015","journal-title":"J. Breast Cancer"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Asano, Y., Kashiwagi, S., Goto, W., Tanaka, S., Morisaki, T., Takashima, T., Noda, S., Onoda, N., Ohsawa, M., and Hirakawa, K. (2017). Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer. Cancers, 9.","DOI":"10.3390\/cancers9010004"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12935-024-03261-0","article-title":"The molecular subtyping and precision medicine in triple-negative breast cancer-based on Fudan TNBC classification","volume":"24","author":"Weng","year":"2024","journal-title":"Cancer Cell Int."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.cmet.2020.10.012","article-title":"Metabolic-Pathway-Based Subtyping of Triple-Negative Breast Cancer Reveals Potential Therapeutic Targets","volume":"33","author":"Gong","year":"2021","journal-title":"Cell Metab."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1158\/1078-0432.CCR-14-1209","article-title":"Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA","volume":"21","author":"Ooi","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.cmet.2016.08.011","article-title":"LDHA-Associated Lactic Acid Production Blunts Tumor Immunosurveillance by T and NK Cells","volume":"24","author":"Brand","year":"2016","journal-title":"Cell Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41422-022-00614-0","article-title":"Comprehensive metabolomics expands precision medicine for triple-negative breast cancer","volume":"32","author":"Xiao","year":"2022","journal-title":"Cell Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1016\/j.ymthe.2021.03.003","article-title":"Bulk and single-cell transcriptome profiling reveal the metabolic heterogeneity in human breast cancers","volume":"29","author":"Yu","year":"2021","journal-title":"Mol. Ther."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s43018-024-00725-0","article-title":"Integrated multiomic profiling of breast cancer in the Chinese population reveals patient stratification and therapeutic vulnerabilities","volume":"5","author":"Jiang","year":"2024","journal-title":"Nat. Cancer"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1038\/s41598-019-57068-5","article-title":"Metabolomics-Based Discovery of Molecular Signatures for Triple Negative Breast Cancer in Asian Female Population","volume":"10","author":"Li","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1002\/1878-0261.13216","article-title":"Predicting dynamic response to neoadjuvant chemotherapy in breast cancer: A novel metabolomics approach","volume":"16","author":"Camacho","year":"2022","journal-title":"Mol. Oncol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10549-024-07370-2","article-title":"Predictive analysis of breast cancer response to neoadjuvant chemotherapy through plasma metabolomics","volume":"207","author":"Yamada","year":"2024","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1186\/s13058-024-01813-w","article-title":"Metabolomics assisted by transcriptomics analysis to reveal metabolic characteristics and potential biomarkers associated with treatment response of neoadjuvant therapy with TCbHP regimen in HER2\u2009+\u2009breast cancer","volume":"26","author":"Zhang","year":"2024","journal-title":"Breast Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"39809","DOI":"10.18632\/oncotarget.9489","article-title":"Pharmacometabolomics study identifies circulating spermidine and tryptophan as potential biomarkers associated with the complete pathological response to trastuzumab-paclitaxel neoadjuvant therapy in HER-2 positive breast cancer","volume":"7","author":"Miolo","year":"2016","journal-title":"Oncotarget"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.molonc.2012.10.003","article-title":"Metabolomics approach for predicting response to neoadjuvant chemotherapy for breast cancer","volume":"7","author":"Wei","year":"2013","journal-title":"Mol. Oncol."},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Hussein, S., Khanna, P., Yunus, N., and Gatza, M.L. (2021). Nuclear Receptor-Mediated Metabolic Reprogramming and the Impact on HR+ Breast Cancer. Cancers, 13.","DOI":"10.3390\/cancers13194808"},{"key":"ref_77","doi-asserted-by":"crossref","unstructured":"Mishra, A., Srivastava, A., Pateriya, A., Tomar, M.S., Mishra, A.K., and Shrivastava, A. (2021). Metabolic reprograming confers tamoxifen resistance in breast cancer. Chem. Biol. Interact., 347.","DOI":"10.1016\/j.cbi.2021.109602"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1158\/0008-5472.CAN-23-0184","article-title":"Metabolomic Rewiring Promotes Endocrine Therapy Resistance in Breast Cancer","volume":"84","author":"Ahn","year":"2024","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast Cancer Treatment: A Review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Leon-Ferre, R.A., and Goetz, M.P. (2023). Advances in systemic therapies for triple negative breast cancer. BMJ, 381.","DOI":"10.1136\/bmj-2022-071674"},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Rushing, B.R., Wiggs, A., Molina, S., Schroder, M., and Sumner, S. (2023). Metabolomics Analysis Reveals Novel Targets of Chemosensitizing Polyphenols and Omega-3 Polyunsaturated Fatty Acids in Triple Negative Breast Cancer Cells. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24054406"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.taap.2011.06.004","article-title":"Sulfur amino acid metabolism in doxorubicin-resistant breast cancer cells","volume":"255","author":"Ryu","year":"2011","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1007\/s11306-013-0517-x","article-title":"Metabolomic approach to evaluating adriamycin pharmacodynamics and resistance in breast cancer cells","volume":"9","author":"Cao","year":"2013","journal-title":"Metabolomics"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"3846","DOI":"10.3390\/md11103846","article-title":"Functional metabolomics uncovers metabolic alterations associated to severe oxidative stress in MCF7 breast cancer cells exposed to ascididemin","volume":"11","author":"Morvan","year":"2013","journal-title":"Mar. Drugs"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Kordias, D., Kostara, C.E., Papadaki, S., Verigos, J., Bairaktari, E., and Magklara, A. (2022). Omics Analysis of Chemoresistant Triple Negative Breast Cancer Cells Reveals Novel Metabolic Vulnerabilities. Cells, 11.","DOI":"10.3390\/cells11172719"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"3225","DOI":"10.1021\/acs.jproteome.6b00430","article-title":"Metabolomics Analysis of Hormone-Responsive and Triple-Negative Breast Cancer Cell Responses to Paclitaxel Identify Key Metabolic Differences","volume":"15","author":"Stewart","year":"2016","journal-title":"J. Proteome Res."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1158\/1078-0432.CCR-24-0195","article-title":"Metabolomic Prediction of Breast Cancer Treatment\u2013Induced Neurologic and Metabolic Toxicities","volume":"30","author":"Piffoux","year":"2024","journal-title":"Clin. Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","unstructured":"Thonusin, C., Nawara, W., Arinno, A., Khuanjing, T., Prathumsup, N., Ongnok, B., Chattipakorn, S.C., and Chattipakorn, N. (2023). Effects of melatonin on cardiac metabolic reprogramming in doxorubicin-induced heart failure rats: A metabolomics study for potential therapeutic targets. J. Pineal Res., 75.","DOI":"10.1111\/jpi.12884"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12967-024-05088-9","article-title":"Changes in blood metabolomes as potential markers for severity and prognosis in doxorubicin-induced cardiotoxicity: A study in HER2-positive and HER2-negative breast cancer patients","volume":"22","author":"Thonusin","year":"2024","journal-title":"J. Transl. Med."},{"key":"ref_90","doi-asserted-by":"crossref","unstructured":"Lyon, D.E., Yao, Y., Garrett, T., Kelly, D.L., Cousin, L., and Archer, K.J. (2023). Comparison of serum metabolomics in women with breast Cancer Prior to Chemotherapy and at 1 year: Cardiometabolic implications. BMC Women\u2019s Health, 23.","DOI":"10.1186\/s12905-023-02355-7"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13058-024-01956-w","article-title":"Serum metabolomic profiling for predicting therapeutic response and toxicity in breast cancer neoadjuvant chemotherapy: A retrospective longitudinal study","volume":"27","author":"Fang","year":"2025","journal-title":"Breast Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/nbm.2798","article-title":"Lactate and glycine-potential MR biomarkers of prognosis in estrogen receptor-positive breast cancers","volume":"25","author":"Lundgren","year":"2012","journal-title":"NMR Biomed"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Cao, M.D., Giske\u00f8deg\u00e5rd, G.F., Bathen, T.F., Sitter, B., Bofin, A., Lonning, P.E., Lundgren, S., and Gribbestad, I.S. (2012). Prognostic value of metabolic response in breast cancer patients receiving neoadjuvant chemotherapy. BMC Cancer, 12.","DOI":"10.1186\/1471-2407-12-39"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"3649","DOI":"10.1021\/acs.jproteome.9b00316","article-title":"Assessing Treatment Response and Prognosis by Serum and Tissue Metabolomics in Breast Cancer Patients","volume":"18","author":"Debik","year":"2019","journal-title":"J. Proteome Res."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Talarico, M.C.R., Derchain, S., da Silva, L.F., Sfor\u00e7a, M.L., Rocco, S.A., Cardoso, M.R., and Sarian, L.O. (2024). Metabolomic Profiling of Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy for Predicting Disease-Free and Overall Survival. Int. J. Mol. Sci., 25.","DOI":"10.3390\/ijms25168639"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2114\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:59:01Z","timestamp":1771952341000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/5\/2114"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,24]]},"references-count":95,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["ijms27052114"],"URL":"https:\/\/doi.org\/10.3390\/ijms27052114","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,24]]}}}